Similarly, both pS6 and pAKT are significantly overexpressed in feline cutaneous squamous cell carcinomas (CSCC), suggesting the mTOR pathway plays a critical role in the pathogenesis of feline CSCC and may represent a potential therapeutic target [56]. The gene discussed is TAS2R63P; the disease is skin squamous cell carcinoma.